The utility of pharmacogenetic testing to support the treatment of bipolar disorder

Marta Ielmini,1 Nicola Poloni,1 Ivano Caselli,1 Jordi Espadaler,2 Miquel Tuson,2 Alessandro Grecchi,3 Camilla Callegari1 1Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy; 2AB-BIOTICS S.A, R&D Unit, Sant Cugat del Valles, Barcelona, Spain; 3AS...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ielmini M, Poloni N, Caselli I, Espadaler J, Tuson M, Grecchi A, Callegari C
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2018-03-01
Colección:Pharmacogenomics and Personalized Medicine
Materias:
Pharmacogenetics testing
bipolar disorder
personalized medicine
pharmacogenetics
adverse events
Acceso en línea:https://www.dovepress.com/the-utility-of-pharmacogenetic-testing-to-support-the-treatment-of-bip-peer-reviewed-article-PGPM
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares